Displaying 1 - 1 of 1
| Active Ingredient | OESTROGENS CONJUGATED |
| Therapeutic Class | ESTROGENS |
| Indications |
Prevention of post-menopausal osteoporosis.Atrophic vaginitis; atrophic urethritis, estrogen replacement.HRT (may be cyclical and progestogen should be added for 10-14 days of the cy le or may be More ... |
| Caution |
Headache, nausea, hypertension, vaginal bleeding, weight changes. c.f. prescribing in liver disease p. 16. |
| Dose Range | Oral: 0.3-1.25mg daily .; i.v/i.m: 25mg may repeat in 6-12 hours if necessary; vaginal cream: 2-4g daily for 3 weeks, off for 1 week then repeat . Breast Cancer: 10 mg three times daily for at least 3 months. Prostate Cancer: 1.25 - 2.5mg 3 times daily . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |